Compounds > diclofenac

diclofenac and su 11248

diclofenac has been researched along with su 11248 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chakravarthi, S; Haleagrahara, N; Judson, JP; Segarra, I; Tan, JR1
Choo, YW; Fernández, C; Lim, SH; Mariño, EL; Modamio, P; Ooi, IH; Segarra, I; Tan, SY; Tiew, AL; Wong, MM1
Chee, EL; Chee, YL; Chew, CC; Fernández, C; Koo, TW; Liew, MH; Mariño, EL; Modamio, P; Ng, S; Segarra, I1

Reviews

1 review(s) available for diclofenac and su 11248

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for diclofenac and su 11248

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Potential protective effect of sunitinib after administration of diclofenac: biochemical and histopathological drug-drug interaction assessment in a mouse model.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:7

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Brain; Chemical and Drug Induced Liver Injury; Creatinine; Diclofenac; Drug Interactions; Indoles; Kidney; Liver; Male; Mice; Mice, Inbred ICR; Myocardium; Protective Agents; Protein Kinase Inhibitors; Pyrroles; Spleen; Sunitinib

2013
Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice.
    Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:4

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Diclofenac; Drug Interactions; Female; Ibuprofen; Indoles; Male; Mefenamic Acid; Mice; Mice, Inbred ICR; Pyrroles; Sex Characteristics; Sunitinib; Tissue Distribution

2016
Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.
    Investigational new drugs, 2017, Volume: 35, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Brain; Diclofenac; Drug Interactions; Female; Indoles; Kidney; Liver; Male; Mice, Inbred ICR; Protein Kinase Inhibitors; Pyrroles; Sex Characteristics; Sunitinib; Tissue Distribution

2017